BF Biosciences Limited (PSX:BFBIO)
139.40
+0.86 (0.62%)
At close: Mar 12, 2026
BF Biosciences Market Cap
BF Biosciences has a market cap or net worth of 12.24 billion as of March 12, 2026. Its market cap has decreased by -29.25% in one year.
Market Cap
12.24B
Enterprise Value
11.98B
Revenue
8.22B
Ranking
n/a
PE Ratio
20.43
Stock Price
139.40
Market Cap Chart
Since October 22, 2024, BF Biosciences's market cap has increased from 7.41B to 12.24B, an increase of 65.20%. That is a compound annual growth rate of 43.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 12.24B | -1.41% |
| Dec 31, 2025 | 12.41B | -40.17% |
| Dec 31, 2024 | 20.75B | 180.05% |
| Oct 22, 2024 | 7.41B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanceon | 13.36B |
| Archroma Pakistan | 13.13B |
| Macter International | 12.89B |
| Ittehad Chemicals | 12.85B |
| Siemens (Pakistan) Engineering | 12.42B |
| Century Paper & Board Mills | 12.25B |
| Samba Bank | 11.79B |
| Atlas Insurance | 10.73B |